Article
ABCC8 polymorphisms are associated with triglyceride concentration in type 2 diabetics on sulfonylurea therapy.
Genetic testing and molecular biomarkers - 1 Aug 2012
Nikolac Nora, Simundic Ana-Maria, Saracevic Andrea, Katalinic Darko
Abstract excerpt
BACKGROUND: The failure of therapy with oral hypoglycemic drugs leads to not only poorly regulated glycemic status, but also dyslipidemia and increased body weight and body mass index (BMI). Sulfonylureas act as insulin secretagogues by binding to the sulfonylurea receptor (SUR-1) encoded by the gene ABCC8. The aim of this study was to explore whether there is an association of ABCC8 polymorphisms SUR1 exon 16...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
